Hennion & Walsh Asset Management, Inc. Annexon, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Annexon, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 477,567 shares of ANNX stock, worth $730,677. This represents 0.05% of its overall portfolio holdings.
Number of Shares
477,567
Previous 429,584
11.17%
Holding current value
$730,677
Previous $2.2 Million
50.39%
% of portfolio
0.05%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding ANNX
# of Institutions
155Shares Held
98MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$11.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$10.7 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$10.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$9.64 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$8.61 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $72.9M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...